MedTrace Logo

Automated Telephone Monitoring for Symptom Management

NCT00799084 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 526

Last updated 2011-12-07

No results posted yet for this study

Summary

To improve the management of symptoms, patients with cancer undergoing chemotherapy will be monitored using an automated telephone system to record the severity of 15 prevalent symptoms for up to 8 consecutive weeks. Outcomes include; significant reduction in symptom severity and improvement in health states.

Conditions

  • Carcinoma

Interventions

BEHAVIORAL

Nurse

Receives 6 telephone calls over 8 weeks from an oncology nurse to assist with symptom management

BEHAVIORAL

AVR

Receives 6 telephone calls over 8 weeks from an programmed automated telephone system to assist with symptom management

Sponsors & Collaborators

Principal Investigators

  • Charles Given, PhD · Michigan State University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2006-11-30
Completion
2006-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00799084 on ClinicalTrials.gov